Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 2,816

Document Document Title
WO/2018/053240A1
Disclosed herein are compounds useful for modulating the mu-opioid receptor ("MOR") and/or delta-opioid receptor ("DOR"), and methods of using these compounds to treat diseases and conditions, such as pain. In particular, disclosed herei...  
WO/2018/020974A1
Provided are the following: a sulfonium salt which does not contain a toxic metal and which exhibits higher cationic polymerization performance and crosslinking performance than a tetrakis(pentafluorophenyl)borate salt; a heat- or photo-...  
WO/2018/014405A1
Provided are a light-emitting material, a preparation method therefor and an organic light-emitting diode using the light-emitting material. The light-emitting material has a single structure, a certain molecular weight, good solubility ...  
WO/2018/014407A1
A light-emitting material, a preparation method therefor, and an organic light-emitting diode made of the light-emitting material. The light-emitting material has a single structure, a determined molecular weight, good solubility and fil...  
WO/2018/014404A1
A light-emitting material, a preparation method therefor and an organic light-emitting diode using said light-emitting material. The light-emitting material is obtained by using m-bromothiophenol and 2-fluoro-4-bromobenzonitrile as start...  
WO/2018/013930A1
Embodiments of the present disclosure pertain to methods of opening a lipid bilayer by associating the lipid bilayer with a molecule that includes a moving component capable of moving (e.g., rotating) in response to an external stimulus;...  
WO/2018/003470A1
Because a sulfonium salt that does not contain a toxic metal and that exhibits polymerization performance and crosslinking reaction performance equal to or greater than those of a tetrakis (pentafluorophenyl) borate salt, a photoacid gen...  
WO/2017/220425A1
A specific mixture of polymerizable photoinitiators containing a thioxanthone group is disclosed. A method for manufacturing this mixture by flow chemistry is also disclosed.  
WO/2017/220205A1
The present invention relates to a compound, which can be used as an anti-bacterial and/or an anti-fungal agent as well as a zinc sensor. Moreover, the present invention relates to a pharmaceutical composition comprising said compound an...  
WO/2017/152725A1
Disclosed are a retinoid compound, a preparation method therefor, intermediates thereof and an application thereof. The retinoid compound I of the present invention has a good tumor growth inhibition rate.  
WO/2017/131047A1
The presentt invention addresses the problem of providing a photocuring method that obtains a crosslinked product (resin) quickly and efficiently, a compound used in the photocuring method, and a photocurable resin composition containing...  
WO/2017/129483A1
The invention relates to a novel hetero-diels-alder cross-linker, to methods for the production thereof and use thereof for reversibly crosslinked polymer systems.  
WO/2017/097746A1
The invention relates to a dextrorotatory enantiomer of a configurational stereoisomer of difethialone, referred to as a hetero-stereoisomer, of formula 3-(4'-bromobiphenyl-4-yl)-1-(4-hydroxythiocoumarin-3-yl)-1,2 ,3,4-tetrahydronaphthal...  
WO/2017/097744A1
The invention relates to a dextrorotatory enantiomer of the configurational stereoisomer of difethialone, referred to as a homo-stereoisomer, of formula 3-(4'-bromobiphenyl-4-yl)-1-(4-hydroxythiocoumarin-3-yl)-1,2 ,3,4-tetrahydronaphthal...  
WO/2017/097747A1
The invention relates to a levorotatory enantiomer of the configurational stereoisomer of difethialone, referred to as a hetero-stereoisomer, of formula 3-(4'-bromobiphenyl-4-yl)-1-(4-hydroxythiocoumarin-3-yl)-1,2 ,3,4-tetrahydronaphthal...  
WO/2017/097745A1
The invention relates to a levorotatory enantiomer of the configurational stereoisomer of difethialone, referred to as a homo-stereoisomer, of formula 3-(4'-bromobiphenyl-4-yl)-1-(4-hydroxythiocoumarin-3-yl)-1,2 ,3,4-tetrahydronaphthalen...  
WO/2017/075927A1
Disclosed in the present invention is a living free radical polymerization based on combined use of aromatic cyclic thia-(oxa-) thioketone, derivatives of the aromatic cyclic thia-(oxa-) thioketone and free radical initiators. According ...  
WO/2017/072792A1
The present invention provides novel heterocyclic compounds as anticancer agents, especially as estrogen receptor (ER) antagonists/ degraders and process for their preparation.  
WO/2017/044575A1
A genus of arylsulfonamide derivatives of heterocyclic constrained tricyclic compounds is disclosed. The compounds are of the following genus: The compounds induce FOXO1 transcription factor translocation to the nucleus by modulating PP2...  
WO/2017/032442A1
The present invention relates to novel compounds, particularly to compounds comprising a photoactive unit, said novel compounds being particularly suitable for ophthalmic devices as well as to ophthalmic devices comprising such compounds.  
WO/2016/200934A1
Compounds, compositions and methods useful for treating cancer and neiirodegeneration are provided. The compounds comprise a mitochondria-targeting moiety linked to β-lapachone or a β-lapachone derivative.  
WO/2016/192610A1
The present invention provides a compound having a novel acyloxime ester structure of the structure shown in a general formula I. The compound has a desirable ultraviolet absorption effect. The compound has characteristics of desirable s...  
WO/2016/192611A1
The present invention provides a compound having an acyloxime ester structure of the structural shown in a general formula I. The compound has a desirable ultraviolet absorption effect. The compound has characteristics of desirable solub...  
WO/2016/190475A1
The present invention relates to a photocleavable mass tag material and a use thereof and, to: a thiochromene type compound useful in matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry or in matrix-l...  
WO/2016/162389A1
The present invention relates to novel compounds which are useful as functionalized photoinitiators which may be used directly or after further functionalization in various photo-curable coating compositions, including varnishes, lacquer...  
WO/2016/161279A1
There are disclosed compounds of formula (I) that modulate or inhibit the enzymatic activity of indoleamine-2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, suc...  
WO/2016/161269A1
There are disclosed compounds that modulate or inhibit the enzymatic activity of indoleamine 2,3-dioxygenase (IDO), pharmaceutical compositions containing said compounds and methods of treating proliferative disorders, such as cancer, vi...  
WO/2016/149975A1
The present invention provides a thioxanthone-aromatic amine compound and an organic light-emitting device applying same. The thioxanthone-aromatic amine compound comprises a compound as shown in a formula (I) or a formula (II), wherein ...  
WO/2016/126423A2
Z is CR4R5, C=CR4R5 SiR4R5, GeR4R5 NR4a, PR4a, P(O)R4a, O, S, SO, SO2, Se; SeO, SeO2, Te, TeO, or TeO2; R1 - R3 are the same or different at each occurrence and are D, aryl, heteroaryl, alkyl, amino, silyl, germyl, deuterated aryl, deute...  
WO/2016/126423A3
Z is CR4R5, C=CR4R5 SiR4R5, GeR4R5 NR4a, PR4a, P(O)R4a, O, S, SO, SO2, Se; SeO, SeO2, Te, TeO, or TeO2; R1 - R3 are the same or different at each occurrence and are D, aryl, heteroaryl, alkyl, amino, silyl, germyl, deuterated aryl, deute...  
WO/2016/097389A1
The invention relates to benzenesulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonists of retinoid-related orphan rece...  
WO/2016/087017A1
The invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices.  
WO/2016/081813A1
The present disclosure provides chalcogenopyrylium compounds, composite nanostructures comprising the chalcogenopyrylium compounds, and methods of using the compounds and/or composite nanostructures. For example, composite nanostructures...  
WO/2016/066134A1
The present invention relates to six-membered ring benzo derivatives as a DPP-4 inhibitor and a use thereof. In particular, the present invention relates to a compound as shown by formula I, a pharmaceutical composition containing the co...  
WO/2016/062587A1
The present invention relates to a compound of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and G are as defined herein; and wherein the compound of formula (I) is optionally present as an agrochemically acceptable sa...  
WO/2016/003053A1
A compound for a phosphorescent host, according to the present invention, can have a wide band gap by adopting a donor-acceptor-donor (D-A-D) structure and have high triplet energy (ET) and a high glass transition temperature (Tg) by usi...  
WO/2015/183719A1
The invention describes the use of a water-based UV curable inkjet printing ink wherein the ink is basic due to the presence of a tertiary amine, allowing the complete dissolution of an acid functional photoinitiator of Formula I or Form...  
WO/2015/145371A1
The present invention relates to a compound of formula I, or an isotopic form, stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, N-oxide or S-oxide thereof; and processes for their preparati...  
WO/2015/129832A1
 The present invention is a radiosensitive resin composition containing: a polymer having a structural unit that contains the group represented by formula (1); and a radiosensitive acid generator. In formula (1), R1 is a substituted or...  
WO/2015/125572A1
A method for producing a thiopyranose compound represented by formula (2), which comprises reacting a compound represented by formula (1) with a sulfur compound. X represents a leaving group; A represents an oxygen atom or a sulfur atom;...  
WO/2015/107542A3
The present invention relates to a method of treating acne or psoriasis by topically administering Tazarotene substantially free of dimer impurity of formula 4,4-dimethyl-6-[4-(4,4-dimethylthiochroman-6-yl)-buta-1,3-di ynyl]-thiochroman.  
WO/2015/083663A1
A purpose of the present invention is to provide a polymerizable monomer having low contamination with respect to liquid crystals, high sensitivity to light of long wavelengths, and an exceptional sensitizing effect, and a polymer compou...  
WO/2015/076395A1
The present invention addresses the problem of providing: an acid- and radical-generating agent which has high sensitivity to an active energy ray having a wavelength of about 300 to 450 nm, can exhibit both high acid-generating ability ...  
WO/2015/062935A1
A process for the preparation of optionally asymmetric acetal compounds, comprising reacting a compound containing a hydroxyl group with a vinylether compound in the presence of a zwitterionic catalyst including at least one basic nitrog...  
WO/2015/044229A1
The invention relates to new PI3K/AKT/m TOR inhibitors and their use for the prevention and/or the treatment of a disease selected from the group consisting of: inflammatory diseases, autoimmune diseases, neurodegenerative diseases, canc...  
WO/2015/032069A1
Provided is a photo-initiator of formula (I), wherein PI is a photo-initiator group containing an aromatic ring capable of initiating a free-radical polymerization reaction when being exposed to actinic radiation, and is connected to Y t...  
WO/2015/032942A1
The invention relates to a compound of Formula (I) and its use as a selective dipeptidyl peptidase I inhibitor, as well as pharmaceutical compositions comprising said compound, and methods of treatment involving said compounds.  
WO/2015/030189A1
Provided is a compound which exhibits bone formation acceleration activity (and/or bone resorption suppression activity). The compound is either a compound having a general formula (I) (wherein the substituents are as defined in the desc...  
WO/2015/002230A1
The present invention relates to compounds (I), which have RORγt inhibitory effects, and salts thereof. In formula (I), each notation is as described in the Specification. (I)  
WO/2014/185303A1
Provided are: a base amplifier that can be used in the cross-linking reaction of an epoxy compound or the like, that is capable of generating a new base as a result of the presence of a base, that is highly soluble with respect to organi...  

Matches 1 - 50 out of 2,816